Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Nutr Biochem ; 74: 108229, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31698204

RESUMO

Systemic lupus erythemathosus (SLE) is a chronic inflammatory and autoimmune disease which can affect multiple organ systems, without an effective and safe treatment. Olive leaf extracts are of special interest for their therapeutic effects. Oleuropein (OL) is the most abundant constituents of olive leaf extract and possesses many beneficial properties. In this study, we evaluated the effects of dietary OL and its new derivate, peracetylated oleuropein (Per-OL), in a pristane-induced SLE model. Mice received an injection of pristane or saline solution and were fed with experimental diets: enriched with OL and Per-OL. The levels of proinflammatory cytokines and markers were evaluated by enzyme-linked immunosorbent assay. The protein expressions of inducible nitric oxide synthase, microsomal prostaglandin E synthase 1, heme oxygenase (HO-1), nuclear factor E2-related factor 2 (Nrf2), mitogen-activated protein kinases (MAPKs), Janus kinase/signal transducer and activator of transcription (JAK/STAT), nuclear transcription factor-kappa B (NF-κB) and inflammasome nucleotide-binding domain, leucine-rich repeats-containing family, pyrin domain-containing-3 (NLRP3) pathways activation were determined in kidneys by Western blot. OL and Per-OL significantly reduced renal damage and decreased serum matrix metalloproteinase 3 and prostaglandine E2 kidneys levels. Our findings indicate that Nrf2 and HO-1 antioxidant protein expressions were up-regulated in mice fed with OL and Per-OL diets, whereas the activation of JAK/STAT, MAPK, NF-κB and NLRP3 inflammasome pathways was significantly ameliorated. These results suggest that OL and Per-OL supplementation might provide a new alternative approach as a preventive/palliative treatment of nephritis in SLE management.


Assuntos
Inflamassomos/efeitos dos fármacos , Iridoides/farmacologia , Nefrite Lúpica/dietoterapia , Animais , Suplementos Nutricionais , Modelos Animais de Doenças , Heme Oxigenase-1/metabolismo , Inflamassomos/metabolismo , Glucosídeos Iridoides , Janus Quinases/metabolismo , Rim/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , Nefrite Lúpica/induzido quimicamente , Nefrite Lúpica/metabolismo , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Metaloproteinase 3 da Matriz/metabolismo , Proteínas de Membrana/metabolismo , Camundongos Endogâmicos BALB C , NF-kappa B/metabolismo , Proteína 3 que Contém Domínio de Pirina da Família NLR/metabolismo , Óxido Nítrico Sintase Tipo II/metabolismo , Fatores de Transcrição STAT/metabolismo , Terpenos/toxicidade
2.
Bioorg Med Chem Lett ; 11(18): 2555-9, 2001 Sep 17.
Artigo em Inglês | MEDLINE | ID: mdl-11549468

RESUMO

Readily derived from D-glucose, 5-[(2R,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]-2-methyl-3-furoic esters and amides are selective and competitive inhibitors (K(i)> or = 3 microM) of alpha-L-fucosidase from bovine epididymis and from human placenta.


Assuntos
Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , alfa-L-Fucosidase/antagonistas & inibidores , Animais , Bovinos , Desenho de Fármacos , Avaliação Pré-Clínica de Medicamentos , Epididimo/enzimologia , Feminino , Furanos/química , Concentração Inibidora 50 , Masculino , Placenta/enzimologia , Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...